Sistema's Sistema-Biotech company has developed a technology for producing recombinant therapeutic proteins. Such proteins are used to produce biotechnological drugs based on monoclonal antibodies, including in the treatment of autoimmune diseases and oncology. Some Russian companies with R&D laboratories have such developments, but they are used only at their own production facilities, while Sistema-Biotech will offer this solution to the whole market for the first time.